Tackling Alzheimer’s Session 1

Thought Leadership
Written By Knapsack

Moderated by George Vradenburg, Co-Chair, Davos Alzheimer’s Collaborative

With 9.9 million new cases of dementia globally each year, the type of collective action witnessed during the COVID-19 pandemic is urgently needed.

What policies, practices and partnerships can help to develop new diagnostics and treatments for Alzheimer’s?

This session is associated with the Davos Alzheimer's Collaborative, convened by the Global CEO Initiative on Alzheimer's Disease (CEOi) and the World Economic Forum.

The first part of this session is open to the public online; the second is only accessible via TopLink.

Speakers

  • George Vrandenburg III
    Chairman of the Board, Davos Alzheimer's Collaborative

  • Haruo Naito
    Representative Corporate Officer and Chief Executive Officer, Eisai Co. Ltd

  • Margaret Chan
    Founding Dean and Vanke Chair Professor, Vanke School of Public Health, Tsinghua University

  • Andrea Pfeifer
    Chief Executive Officer, AC Immune SA

  • Arnaud Bernaert
    Head, Health Security Solutions, SICPA SA

Knapsack http://www.knapsackcreative.com
Previous

Positive Data on Eli Lilly’s Alzheimer’s Drug and Many Other Catalysts Suggest Cassava Sciences’ Run is Just Getting Started
Next

Tackling Alzheimer’s Session 2